|
Volumn 126, Issue 11, 2013, Pages 937-938
|
Atrial fibrillation: Food for thought in 2013
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
COLCHICINE;
PLACEBO;
FIBRINOLYTIC AGENT;
ANTICOAGULANT THERAPY;
CARDIOVASCULAR RISK;
CARDIOVASCULAR SURGERY;
CATHETER ABLATION;
CEREBROVASCULAR ACCIDENT;
CHA2DS2 VASC SCORE;
CHADS2 SCORE;
DEMENTIA;
EDITORIAL;
EXERCISE TOLERANCE;
GROUPS BY AGE;
HEART ATRIUM FIBRILLATION;
HEART FAILURE;
HEART LEFT VENTRICLE CONTRACTION;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
KIDNEY FAILURE;
LEFT VENTRICULAR DIASTOLIC DYSFUNCTION;
LOW DRUG DOSE;
OUTCOME ASSESSMENT;
POPULATION;
POSTOPERATIVE COMPLICATION;
PREVALENCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SEX DIFFERENCE;
SINUS RHYTHM;
SURVIVAL;
TACHYCARDIA;
THROMBOEMBOLISM;
UNSPECIFIED SIDE EFFECT;
ATRIAL FIBRILLATION;
COMPLICATION;
HEALTH;
RISK ASSESSMENT;
RISK FACTOR;
STROKE;
ATRIAL FIBRILLATION;
CATHETER ABLATION;
FIBRINOLYTIC AGENTS;
GLOBAL HEALTH;
HUMANS;
RISK ASSESSMENT;
RISK FACTORS;
STROKE;
THROMBOEMBOLISM;
|
EID: 84886437102
PISSN: 00029343
EISSN: 15557162
Source Type: Journal
DOI: 10.1016/j.amjmed.2013.02.038 Document Type: Editorial |
Times cited : (4)
|
References (11)
|